Grantham, Mayo, Van Otterloo & Co. LLC

SEC CIK: 0001352662
Latest filing: Aug 13, 2026

SEC filings (opens in a new tab)

REGN holding history

Regeneron Pharmaceuticals, Inc. in every 13F filed by Grantham, Mayo, Van Otterloo & Co. LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

REGN overview All 13F holders of REGN Full Q2 2026 holdings

Shares (Q2 2026): 74,200
Value: $46.3M
% of portfolio: 0.1%
Quarters held: 22; Since Q1 2021

Holdings of REGN by Grantham, Mayo, Van Otterloo & Co. LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	74,200	$46.3M	0.1%	+18,847+34.0%	Added	Holders
Q1 2026	55,353	$42.8M	0.1%	−1,351−2.4%	Reduced	Holders
Q4 2025	56,704	$43.8M	0.1%	−4,770−7.8%	Reduced	Holders
Q3 2025	61,474	$34.6M	0.1%	−3,809−5.8%	Reduced	Holders
Q2 2025	65,283	$34.3M	0.1%	−18,047−21.7%	Reduced	Holders
Q1 2025	83,330	$52.9M	0.2%	+20,351+32.3%	Added	Holders
Q4 2024	62,979	$44.9M	0.1%	+10,982+21.1%	Added	Holders
Q3 2024	51,997	$54.7M	0.2%	−5,267−9.2%	Reduced	Holders
Q2 2024	57,264	$60.2M	0.2%	−596−1.0%	Reduced	Holders
Q1 2024	57,860	$55.7M	0.2%	−9,240−13.8%	Reduced	Holders
Q4 2023	67,100	$58.9M	0.3%	+9,160+15.8%	Added	Holders
Q3 2023	57,940	$47.7M	0.2%	+5,036+9.5%	Added	Holders
Q2 2023	52,904	$38.0M	0.2%	−14,238−21.2%	Reduced	Holders
Q1 2023	67,142	$55.2M	0.3%	−4,000−5.6%	Reduced	Holders
Q4 2022	71,142	$51.3M	0.3%	+17,142+31.7%	Added	Holders
Q3 2022	54,000	$37.2M	0.2%	−2,400−4.3%	Reduced	Holders
Q2 2022	56,400	$33.3M	0.2%	+8,500+17.7%	Added	Holders
Q1 2022	47,900	$33.5M	0.2%	+500+1.1%	Added	Holders
Q4 2021	47,400	$29.9M	0.1%	−1,900−3.9%	Reduced	Holders
Q3 2021	49,300	$29.8M	0.1%	+800+1.6%	Added	Holders
Q2 2021	48,500	$27.1M	0.1%	+6,900+16.6%	Added	Holders
Q1 2021	41,600	$19.7M	0.1%	–	–	Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.